William Blair Investment Management
CRL icon

William Blair Investment Management’s Charles River Laboratories CRL Stock Holding History

William Blair Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-364,614
Closed -$98.8M – 424
2024
Q1 		$98.8M Sell
364,614
-5,989
-2% -$1.43M 0.26% 118
2023
Q4 		$87.6M Sell
370,603
-15,615
-4% -$3.07M 0.26% 115
2023
Q3 		$75.7M Sell
386,218
-8,041
-2% -$1.65M 0.25% 112
2023
Q2 		$82.9M Sell
394,259
-301,716
-43% -$60M 0.27% 110
2023
Q1 		$140M Sell
695,975
-14,045
-2% -$3.18M 0.49% 65
2022
Q4 		$155M Sell
710,020
-17,536
-2% -$3.83M 0.59% 53
2022
Q3 		$143M Sell
727,556
-277,643
-28% -$59.9M 0.57% 59
2022
Q2 		$215M Sell
1,005,199
-30,769
-3% -$7.52M 0.8% 27
2022
Q1 		$294M Sell
1,035,968
-40,282
-4% -$12.4M 0.88% 23
2021
Q4 		$406M Buy
1,076,250
+133,654
+14% +$51.9M 1.1% 10
2021
Q3 		$389M Sell
942,596
-35,882
-4% -$14.9M 1.1% 11
2021
Q2 		$362M Sell
978,478
-13,702
-1% -$4.58M 1.14% 13
2021
Q1 		$288M Buy
992,180
+861,234
+658% +$239M 0.93% 23
2020
Q4 		$32.7M Sell
130,946
-34,866
-21% -$8.3M 0.11% 164
2020
Q3 		$37.5M Buy
+165,812
New +$34.4M 0.15% 142
2018
Q3 		– Sell
-1,671,909
Closed -$188M – 439
2018
Q2 		$188M Sell
1,671,909
-36,614
-2% -$3.96M 0.7% 35
2018
Q1 		$182M Buy
1,708,523
+301,779
+21% +$32.5M 0.7% 38
2017
Q4 		$154M Buy
1,406,744
+1,361,626
+3,018% +$148M 0.6% 45
2017
Q3 		$4.87M Buy
+45,118
New +$4.64M 0.02% 356

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

William Blair Investment Management's CRL Position: Q2 2024 in Review

William Blair Investment Management sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 364,614 shares — an estimated $98.8M sold.

William Blair Investment Management first reported a position in CRL in Q3 2017 and held it in 19 quarters. The position peaked at $406M in Q4 2021. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • William Blair Investment Management reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • William Blair Investment Management sold 364,614 Charles River Laboratories shares in Q2 2024, an estimated $98.8M.
  • William Blair Investment Management first reported a position in Charles River Laboratories in Q3 2017 and held it in 19 quarters.
  • William Blair Investment Management's Charles River Laboratories position peaked at $406M in Q4 2021.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on William Blair Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.